急性髓性白血病的治疗障碍:白血病干细胞,炎症和免疫功能障碍
Bofei Wang1, Patrick K Reville1, Hussein A Abbas2
1Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Current opinion in pharmacology
|May 3, 2025
概括
急性髓性白血病 (AML) 治疗面临的挑战是由于白血病干细胞 (LSC) 和免疫逃避,导致生存率低下. 需要创新策略来克服LSC驱动的耐药性,并改善AML患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 急性髓性白血病 (AML) 是一种具有攻击性的血液恶性瘤,尽管目前的治疗方法,但长期生存率不佳.
- 治疗挑战包括AML中的复发,折射性和复杂的细胞层次结构.
研究的目的:
- 探索AML治疗当前的挑战.
- 专注于白血病干细胞 (LSC) 驱动的抵抗和免疫逃避机制.
- 突出在AML中需要创新的治疗策略.
主要方法:
- 这是一个简短的复习文章.
- 它综合了当前关于AML治疗挑战的知识.
- 专注于LSC生物学和免疫逃避.
主要成果:
- 白血病干细胞 (LSCs) 和它们与骨髓利基的相互作用有助于治疗耐药性.
- 免疫功能障碍,包括T细胞枯竭和免疫抑制,加剧了AML的治疗抵抗.
- 缺乏特定的LSC标记物和LSC功能异质性使向治疗复杂化.
结论:
- 目前的AML治疗面临着重大障碍,主要是由LSC和免疫逃避驱动的.
- 新的治疗方法对于克服耐药性和改善AML患者的存活率至关重要.
- 对LSC生物学和免疫调节的进一步研究对于推进AML治疗至关重要.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
Disorders of Leukocytes
782
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
782
Bone Marrow Sampling and Transplants
266
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
266


